PharmaShots | Incisive News in 3 Shots

Subscribe Now

Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell

Amgen's BLINCYTO (blinatumomab- BiTE) Receives EU Expanded approval for pediatric 2L+ B-cell-ALL

Amgen's BLINCYTO (blinatumomab- BiTE) Receives EU Expanded approval for pediatric 2L+ B-cell-ALL

August 30, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us